Results Primary Cohort After applying the inclusion and exclusion criteria, we identified 413 patients in the main cohort who achieved HbA1c 300 mg/g decreased from 6.5% at baseline to 4.1% in the 1st year and 5.5% in the 2nd year (shown in Supplementary Fig
Maintain your current dose when switching
Who Is a Candidate, and Who Is Not Im generally seeing a wellness candidate somewhere between 30 and 65 whos generally healthy, free of active malignancy, free of infection and willing to go through the multi-month journey with appropriate follow-up appointments
For most, nausea is most prominent during the first few weeks and lessens over time
Oral (sublingual) semaglutide: $249/month month-to-month, with a $179/month tier
Know the signs of severe reactions that require immediate medical attention, such as difficulty breathing, severe allergic reactions, or sudden changes in vision